Back to results
US 2022/0033391 A1Published application
Solid form, crystalline form, and crystal form a of fxr agonist, and preparation method and application thereof
AssigneeCspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
InventorsXiaolin Li, Peng Li, Haiying He
Life of this patent
Estimating the term…
Abstract
Disclosed are a solid form, a crystalline form, and crystal form A of a compound of formula (I) used as an FXR agonist, and a preparation method therefor. Also comprised is an application of the compound of formula (I) in preparation of a medication for treating nonalcoholic steatohepatitis (NASH).
Claims27
A solid form of a compound of formula (I)
(canceled)
(canceled)
A method for preparing the compound of formula (I), comprising the following steps:
- wherein R1 is C1-3 alkyl group.
A compound represented by formula e, or a pharmaceutically acceptable salt thereof,
- wherein R1 is C1-3 alkyl group.
(canceled)
Dependencies are inferred from the claim text.